Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.

Sullivan HW, O'Donoghue AC, Lynch M, Johnson M, Davis C, Rupert DJ.

Med Decis Making. 2019 Oct 4:272989X19875946. doi: 10.1177/0272989X19875946. [Epub ahead of print]

PMID:
31583947
2.

Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation.

O'Donoghue AC, Johnson M, Sullivan HW, Parvanta S, Ray S, Southwell BG.

J Health Commun. 2019;24(4):368-376. doi: 10.1080/10810730.2019.1606364. Epub 2019 Apr 23.

PMID:
31012394
3.

Actors in whitespace: Communicating risk information on pharmaceutical websites.

O'Donoghue AC, Sullivan HW, Rupert DJ, Fitts Willoughby J, Aikin KJ.

Health Mark Q. 2019 Apr-Jun;36(2):152-167. doi: 10.1080/07359683.2019.1575063. Epub 2019 Mar 23.

PMID:
30907290
4.

Author Correction: The identification of carbon dioxide mediated protein post-translational modifications.

Linthwaite VL, Janus JM, Brown AP, Wong-Pascua D, O'Donoghue AC, Porter A, Treumann A, Hodgson DRW, Cann MJ.

Nat Commun. 2018 Oct 3;9(1):4131. doi: 10.1038/s41467-018-06711-2.

5.

Disclosing accelerated approval on direct-to-consumer prescription drug websites.

Sullivan HW, O'Donoghue AC, David KT, Patel NJ.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1277-1280. doi: 10.1002/pds.4664. Epub 2018 Sep 28.

PMID:
30264874
6.

The identification of carbon dioxide mediated protein post-translational modifications.

Linthwaite VL, Janus JM, Brown AP, Wong-Pascua D, O'Donoghue AC, Porter A, Treumann A, Hodgson DRW, Cann MJ.

Nat Commun. 2018 Aug 6;9(1):3092. doi: 10.1038/s41467-018-05475-z. Erratum in: Nat Commun. 2018 Oct 3;9(1):4131.

7.

Assessing hearing and cognition challenges in consumer processing of televised risk information: Validation of self-reported measures using performance indicators.

Southwell BG, Parvanta SA, Johnson MM, O'Donoghue AC, Sullivan HW, Ray SE, Soloe CS, Davis CN, McKenna N.

Prev Med Rep. 2018 Jun 22;11:145-147. doi: 10.1016/j.pmedr.2018.06.008. eCollection 2018 Sep.

8.

Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion.

Moynihan CK, Burke PA, Evans SA, O'Donoghue AC, Sullivan HW.

J Am Board Fam Med. 2018 Jul-Aug;31(4):645-649. doi: 10.3122/jabfm.2018.04.170242.

9.

Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.

Sullivan HW, O'Donoghue AC, Gard Read J, Amoozegar JB, Aikin KJ, Rupert DJ.

J Med Internet Res. 2018 Jan 23;20(1):e13. doi: 10.2196/jmir.7959.

10.

New Blatter-type radicals from a bench-stable carbene.

Grant JA, Lu Z, Tucker DE, Hockin BM, Yufit DS, Fox MA, Kataky R, Chechik V, O'Donoghue AC.

Nat Commun. 2017 May 15;8:15088. doi: 10.1038/ncomms15088.

11.

Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.

Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Aikin KJ.

J Health Commun. 2017 Feb;22(2):171-181. doi: 10.1080/10810730.2016.1258745. Epub 2017 Jan 27.

PMID:
28129069
12.

Consumer confusion between prescription drug precautions and side effects.

Amoozegar JB, Rupert DJ, Sullivan HW, O'Donoghue AC.

Patient Educ Couns. 2017 Jun;100(6):1111-1119. doi: 10.1016/j.pec.2016.12.032. Epub 2016 Dec 30.

PMID:
28069321
13.

Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.

Aikin KJ, Sullivan HW, O'Donoghue AC, Betts KR.

Health Mark Q. 2016 Oct-Dec;33(4):291-306. Epub 2016 Oct 19.

PMID:
27841741
14.

Peer-Generated Health Information: The Role of Online Communities in Patient and Caregiver Health Decisions.

Rupert DJ, Gard Read J, Amoozegar JB, Moultrie RR, Taylor OM, O'Donoghue AC, Sullivan HW.

J Health Commun. 2016 Nov;21(11):1187-1197. Epub 2016 Nov 2.

PMID:
27805496
15.

Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.

Sullivan HW, O'Donoghue AC, Rupert DJ, Willoughby JF, Amoozegar JB, Aikin KJ.

J Health Commun. 2016 Nov;21(11):1198-1207. Epub 2016 Nov 2.

PMID:
27805473
16.

The synthesis, conformation and hydrolytic stability of an N,S-bridging thiophosphoramidate analogue of thymidylyl-3',5'-thymidine.

Conway LP, Mikkola S, O'Donoghue AC, Hodgson DR.

Org Biomol Chem. 2016 Jul 26;14(30):7361-7. doi: 10.1039/c6ob01270a.

PMID:
27417455
17.

Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.

O'Donoghue AC, Sullivan HW, Williams PA, Squire C, Betts KR, Fitts Willoughby J, Parvanta S.

J Health Commun. 2016 Aug;21(8):927-34. doi: 10.1080/10810730.2016.1179367. Epub 2016 Jul 14.

PMID:
27414000
18.

Professional online community membership and participation among healthcare providers: An extension to nurse practitioners and physician assistants.

Betts KR, O'Donoghue AC, Aikin KJ, Kelly BJ, Boudewyns V.

J Am Assoc Nurse Pract. 2016 Dec;28(12):639-645. doi: 10.1002/2327-6924.12383. Epub 2016 May 23.

PMID:
27214569
19.

Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.

Aikin KJ, Southwell BG, Paquin RS, Rupert DJ, O'Donoghue AC, Betts KR, Lee PK.

Res Social Adm Pharm. 2017 Mar - Apr;13(2):378-388. doi: 10.1016/j.sapharm.2016.04.004. Epub 2016 Apr 22.

PMID:
27178746
20.

Who Said It Better? A Test of Wording Differences in the MedWatch "Toll-Free Statement" for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements.

Aikin KJ, O'Donoghue AC, Sullivan HW, Betts KR, Squire C.

Ther Innov Regul Sci. 2016 Mar;50(2):169-173. doi: 10.1177/2168479015596023.

PMID:
30227007
21.

Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.

Sullivan HW, O'Donoghue AC, Aikin KJ, Chowdhury D, Moultrie RR, Rupert DJ.

Patient Educ Couns. 2016 May;99(5):790-9. doi: 10.1016/j.pec.2015.12.015. Epub 2015 Dec 22.

PMID:
26749356
22.

Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.

Williams PA, O'Donoghue AC, Sullivan HW, Willoughby JF, Squire C, Parvanta S, Betts KR.

Patient Educ Couns. 2016 Apr;99(4):583-590. doi: 10.1016/j.pec.2015.10.019. Epub 2015 Nov 5.

PMID:
26589655
23.

Influence of patient medication information format on comprehension and application of medication information: A randomized, controlled experiment.

Boudewyns V, O'Donoghue AC, Kelly B, West SL, Oguntimein O, Bann CM, McCormack LA.

Patient Educ Couns. 2015 Jul 10. pii: S0738-3991(15)30012-4. doi: 10.1016/j.pec.2015.07.003. [Epub ahead of print]

PMID:
26198545
24.

Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.

O'Donoghue AC, Boudewyns V, Aikin KJ, Geisen E, Betts KR, Southwell BG.

J Health Commun. 2015;20(11):1330-6. doi: 10.1080/10810730.2015.1018649. Epub 2015 Jul 15.

PMID:
26176326
25.

Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study.

Sullivan HW, O'Donoghue AC, Aikin KJ.

Ther Innov Regul Sci. 2015 Jul;49(4):493-502. doi: 10.1177/2168479015572370.

PMID:
30222437
26.

Rate and Equilibrium Constants for the Addition of N-Heterocyclic Carbenes into Benzaldehydes: A Remarkable 2-Substituent Effect.

Collett CJ, Massey RS, Taylor JE, Maguire OR, O'Donoghue AC, Smith AD.

Angew Chem Weinheim Bergstr Ger. 2015 Jun 1;127(23):6991-6996. Epub 2015 Apr 23.

27.

Rate and equilibrium constants for the addition of N-heterocyclic carbenes into benzaldehydes: a remarkable 2-substituent effect.

Collett CJ, Massey RS, Taylor JE, Maguire OR, O'Donoghue AC, Smith AD.

Angew Chem Int Ed Engl. 2015 Jun 1;54(23):6887-92. doi: 10.1002/anie.201501840. Epub 2015 Apr 23.

28.

Understanding thio-effects in simple phosphoryl systems: role of solvent effects and nucleophile charge.

Carvalho AT, O'Donoghue AC, Hodgson DR, Kamerlin SC.

Org Biomol Chem. 2015 May 21;13(19):5391-8. doi: 10.1039/c5ob00309a.

29.

Primary care physicians' use of FDA-approved prescription drug labels.

Sullivan HW, O'Donoghue AC, Aikin KJ.

J Am Board Fam Med. 2014 Sep-Oct;27(5):694-8. doi: 10.3122/jabfm.2014.05.140039.

30.

Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.

O'Donoghue AC, Williams PA, Sullivan HW, Boudewyns V, Squire C, Willoughby JF.

Soc Sci Med. 2014 Nov;120:1-11. doi: 10.1016/j.socscimed.2014.08.039. Epub 2014 Aug 28.

PMID:
25194471
31.

Editorial overview: Mechanisms: Chemical and computational probes of biological mechanism.

O'Donoghue AC, Kamerlin SC.

Curr Opin Chem Biol. 2014 Aug;21:viii-x. doi: 10.1016/j.cbpa.2014.07.025. Epub 2014 Aug 13. No abstract available.

PMID:
25129687
32.

Perceived healthcare provider reactions to patient and caregiver use of online health communities.

Rupert DJ, Moultrie RR, Read JG, Amoozegar JB, Bornkessel AS, O'Donoghue AC, Sullivan HW.

Patient Educ Couns. 2014 Sep;96(3):320-6. doi: 10.1016/j.pec.2014.05.015. Epub 2014 May 29.

PMID:
24923652
33.

Enzyme architecture: the effect of replacement and deletion mutations of loop 6 on catalysis by triosephosphate isomerase.

Zhai X, Go MK, O'Donoghue AC, Amyes TL, Pegan SD, Wang Y, Loria JP, Mesecar AD, Richard JP.

Biochemistry. 2014 Jun 3;53(21):3486-501. doi: 10.1021/bi500458t. Epub 2014 May 22.

34.

Important Safety Information or Important Risk Information? A Question of Framing in Prescription Drug Advertisements.

O'Donoghue AC, Sullivan HW, Aikin KJ, Betts KR.

Ther Innov Regul Sci. 2014 May;48(3):305-307. doi: 10.1177/2168479013510306.

PMID:
30235532
35.

Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.

O'Donoghue AC, Sullivan HW, Aikin KJ.

Ann Behav Med. 2014 Dec;48(3):311-22. doi: 10.1007/s12160-014-9603-1.

PMID:
24682975
36.

Presenting efficacy information in direct-to-consumer prescription drug advertisements.

O'Donoghue AC, Sullivan HW, Aikin KJ, Chowdhury D, Moultrie RR, Rupert DJ.

Patient Educ Couns. 2014 May;95(2):271-80. doi: 10.1016/j.pec.2013.12.010. Epub 2013 Dec 25.

PMID:
24581929
37.

Presenting quantitative information about placebo rates to patients.

Sullivan HW, O'Donoghue AC, Aikin KJ.

JAMA Intern Med. 2013 Nov 25;173(21):2006-7. doi: 10.1001/jamainternmed.2013.10399. No abstract available.

PMID:
24126622
38.

Proton transfer reactions of triazol-3-ylidenes: kinetic acidities and carbon acid pKa values for twenty triazolium salts in aqueous solution.

Massey RS, Collett CJ, Lindsay AG, Smith AD, O'Donoghue AC.

J Am Chem Soc. 2012 Dec 19;134(50):20421-32. doi: 10.1021/ja308420c. Epub 2012 Dec 6.

PMID:
23173841
39.

Hydrolysis studies of phosphodichloridate and thiophosphodichloridate ions.

Delley RJ, O'Donoghue AC, Hodgson DR.

J Org Chem. 2012 Jul 6;77(13):5829-31. doi: 10.1021/jo300808m. Epub 2012 Jun 18.

PMID:
22681395
40.

peri-Dimethylamino substituent effects on proton transfer at carbon in α-naphthylacetate esters: a model for mandelate racemase.

Delley RJ, Bandyopadhyay S, Fox MA, Schliehe C, Hodgson DR, Hollfelder F, Kirby AJ, O'Donoghue AC.

Org Biomol Chem. 2012 Jan 21;10(3):590-6. doi: 10.1039/c1ob06525d. Epub 2011 Nov 23.

PMID:
22108698
41.

pKa values of chiral Brønsted acid catalysts: phosphoric acids/amides, sulfonyl/sulfuryl imides, and perfluorinated TADDOLs (TEFDDOLs).

Christ P, Lindsay AG, Vormittag SS, Neudörfl JM, Berkessel A, O'Donoghue AC.

Chemistry. 2011 Jul 25;17(31):8524-8. doi: 10.1002/chem.201101157. Epub 2011 Jun 28. No abstract available.

PMID:
21714022
42.

Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements.

Aikin KJ, O'Donoghue AC, Swasy JL, Sullivan HW.

Med Decis Making. 2011 Nov-Dec;31(6):E23-33. doi: 10.1177/0272989X11413289. Epub 2011 Jun 20.

PMID:
21690303
43.

pKas of the conjugate acids of N-heterocyclic carbenes in water.

Higgins EM, Sherwood JA, Lindsay AG, Armstrong J, Massey RS, Alder RW, O'Donoghue AC.

Chem Commun (Camb). 2011 Feb 7;47(5):1559-61. doi: 10.1039/c0cc03367g. Epub 2010 Nov 29.

PMID:
21116519
44.

Efficient catalytic promiscuity in an enzyme superfamily: an arylsulfatase shows a rate acceleration of 10(13) for phosphate monoester hydrolysis.

Olguin LF, Askew SE, O'Donoghue AC, Hollfelder F.

J Am Chem Soc. 2008 Dec 10;130(49):16547-55. doi: 10.1021/ja8047943.

PMID:
19554727
45.

Tandem multi-step synthesis of C-carboxyazlactones promoted by N-heterocyclic carbenes.

Campbell CD, Duguet N, Gallagher KA, Thomson JE, Lindsay AG, O'Donoghue AC, Smith AD.

Chem Commun (Camb). 2008 Aug 14;(30):3528-30. doi: 10.1039/b806816j. Epub 2008 Jul 7.

PMID:
18654702
46.

Slow proton transfer from the hydrogen-labelled carboxylic acid side chain (Glu-165) of triosephosphate isomerase to imidazole buffer in D2O.

O'Donoghue AC, Amyes TL, Richard JP.

Org Biomol Chem. 2008 Jan 21;6(2):391-6. doi: 10.1039/b714304d. Epub 2007 Dec 7.

PMID:
18175010
47.

Psychiatric disorders in hypertrophic cardiomyopathy.

Morgan JF, O'Donoghue AC, McKenna WJ, Schmidt MM.

Gen Hosp Psychiatry. 2008 Jan-Feb;30(1):49-54. doi: 10.1016/j.genhosppsych.2007.09.005.

PMID:
18164940
48.

Hydron transfer catalyzed by triosephosphate isomerase. Products of isomerization of dihydroxyacetone phosphate in D2O.

O'Donoghue AC, Amyes TL, Richard JP.

Biochemistry. 2005 Feb 22;44(7):2622-31.

PMID:
15709775
49.
50.

Unexpectedly small ortho-oxygen substituent effects on stabilities of benzylic carbocations.

Fujio M, Keeffe JR, More O'Ferrall RA, O'Donoghue AC.

J Am Chem Soc. 2004 Aug 18;126(32):9982-92.

PMID:
15303872

Supplemental Content

Loading ...
Support Center